Close

Content Team HHMGlobal

Siemens Healthineers Debuts TrueFusion Application for Treatment of Structural Heart Disease

Siemens Healthineers has introduced TrueFusion1, an application on the new Release 5.0 of the ACUSON SC2000 cardiovascular ultrasound system that integrates ultrasound and angiography...

Endomag Receives CE Mark Approval for Magseed Breast Cancer Localisation Technology

Endomag announced today that it has received CE Mark approval for Magseed®, a minimally invasive breast marker used to accurately guide surgeons during breast...

Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer

The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid (1), showed that adding the cyclin-dependent kinase (CDK) 4/6...

New biomarker predicts metastatic prostate cancers

Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are...

NuVasive announces acquisition of Vertera spine medical device company

NuVasive, Inc. , a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the acquisition of Vertera Spine,...

BioPhotas Inc Clears Additional FDA and Intellectual Property Hurdles

BioPhotas, Inc. announced the FDA clearance of the Celluma, its award-winning and patented medical device, for an additional indication-for-use in treating full face wrinkles. The FDA...

Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe

Thermo Fisher Scientific has formed an Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels to help identify predictive...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read